SaintMed Valuation
Is SMD100-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SMD100-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SMD100-R (THB5.85) is trading above our estimate of fair value (THB4.69)
Significantly Below Fair Value: SMD100-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SMD100-R?
Key metric: As SMD100-R is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is SMD100-R's PE Ratio? | |
|---|---|
| PE Ratio | 22.4x |
| Earnings | ฿54.27m |
| Market Cap | ฿1.22b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.3x |
| Enterprise Value/EBITDA | 12.3x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does SMD100-R's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 19.2x | ||
BIZ Business Alignment | 9.4x | n/a | ฿2.1b |
BIS Bioscience Animal Health | 17.2x | n/a | ฿1.1b |
SEI SEI Medical | 21.4x | 25.0% | ฿846.6m |
WINMED Winnergy Medical | 28.6x | n/a | ฿792.0m |
SMD100-R SaintMed | 22.4x | n/a | ฿1.2b |
Price-To-Earnings vs Peers: SMD100-R is expensive based on its Price-To-Earnings Ratio (22.4x) compared to the peer average (19.2x).
Price to Earnings Ratio vs Industry
How does SMD100-R's PE Ratio compare vs other companies in the TH Healthcare Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: SMD100-R is expensive based on its Price-To-Earnings Ratio (22.4x) compared to the TH Healthcare industry average (22x).
Price to Earnings Ratio vs Fair Ratio
What is SMD100-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 22.4x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SMD100-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Master Style
฿12.7b
Operates a cosmetic surgery hospital under the Masterpiece Hospital name in Thailand.
MASTER
฿42.25
7D
-8.2%
1Y
-7.1%
Safe Fertility Group
฿3.6b
Provides fertility medical center services in Thailand.
SAFE
฿12.00
7D
-0.8%
1Y
-33.0%
E for L Aim
฿1.1b
Engages in the distribution of medical devices and equipment in Thailand.
EFORL-R
฿0.28
7D
3.7%
1Y
12.0%